New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

Weight-loss jabs could cut the risk of cancer by almost half – more than obesity surgery, research suggests. Researchers ...

Weight loss jabs, also known as GLP-1 receptor agonists, work by reducing food cravings. Giving obese children weight-loss ...

Hailed as a miracle weight-loss treatment, drugs such as Wegovy and Mounjaro have helped more than 500,000 people shed the ...

Landmark research suggests the appetite-suppressing jabs which mimic a hormone that makes us feel full also significantly cut ...

Health experts presented findings showing the drugs helped severely obese youngsters shed pounds on top of the diet and ...

In fact, co-lead author, Dr Yael Wolff Sagy from Tel-Aviv, Israel, said researchers found a "direct effect" of GLP-1s beyond ...

New research indicates that weight loss injections, or GLP-1 receptor agonists, may directly contribute to cancer risk ...

Weight-loss jabs will be a “game-changer” for the economy, Wes Streeting has said. A study, based on government modelling, ...

Research presented at the the European Congress on Obesity suggests weight loss injections are safe and work for the mentally ...

Mounjaro (tirzepatide) and Wegovy (semaglutide) are weight-loss medicines that make people feel fuller for longer and ...

After hundreds of patients were given the newer jab and typically lost a fifth of their body weight after 72 weeks ...